New York A 3645: Relates to the disposition of campaign funds upon the conviction of a felony of a candidate, former candidate or holder of elective office

Bill Text

Bill Search and Legislative Information | New York State Assembly 

• 

• 

• 

• 

• 

• 

• 

• 

 Skip to main content 

 New York State Assembly

 Speaker Carl E. Heastie

 --> 
 --> 

 --> 

• 
 Assembly Members 

• 
 Legislative Info 

• 
 Public Hearings 

• 
 Speaker's Press 

• 
 Assembly Reports 

• 
 Committees & More 

• Bill Search Home
• Laws
• Legislative Calendar
• Public Hearing Schedule
• Assembly Calendars
• Assembly Committee Agenda 

 Javascript must be enabled to properly view this page. 

 Bill No.: 

• Summary 
• Actions 
• Committee&nbspVotes 
• Floor&nbspVotes 
• Memo 
• Text 
• LFIN 
• Chamber&nbspVideo/Transcript 
A03645 Summary:

BILL NOA03645 

&nbsp

SAME ASSAME AS S02164

&nbsp

SPONSORSimone

&nbsp

COSPNSR

&nbsp

MLTSPNSR

&nbsp

Amd §§3216, 3221 & 4303, Ins L

&nbsp

Requires health insurance policies to include coverage of optional anesthesia for certain contraceptive and menstrual health procedures including, but not limited to, loop electrosurgical excision procedure, colposcopy, ablation, and intrauterine device insertion.

Go to top A03645 Actions:

BILL NOA03645 

&nbsp

01/28/2025referred to insurance

01/07/2026referred to insurance

Go to topA03645 Committee&nbspVotes:

Go to topA03645 Floor&nbspVotes:

There are no Assembly votes for this bill in this legislative session.

Go to topA03645 Text:

 STATE OF NEW YORK
 ________________________________________________________________________

 3645

 2025-2026 Regular Sessions

 IN ASSEMBLY

 January 29, 2025
 ___________

 Introduced by M. of A. SIMONE -- read once and referred to the Committee
 on Insurance

 AN ACT to amend the insurance law, in relation to requiring health
 insurance policies to include coverage of optional anesthesia for
 certain contraceptive and menstrual health procedures

 The People of the State of New York, represented in Senate and Assem-
 bly, do enact as follows:

 1 Section 1. Clause (v) of subparagraph (E) of paragraph 17 of
 2 subsection (i) of section 3216 of the insurance law, as amended by
 3 section 3 of part M of chapter 57 of the laws of 2019, is amended to
 4 read as follows:
 5 (v) all FDA-approved menstrual health procedures and contraceptive
 6 drugs, devices, and other products, including all over-the-counter
 7 contraceptive drugs, devices, and products as prescribed or as otherwise
 8 authorized under state or federal law; voluntary sterilization proce-
 9 dures pursuant to 42 U.S.C. 18022 and identified in the comprehensive
 10 guidelines supported by the health resources and services administration
 11 and thereby incorporated in the essential health benefits benchmark
 12 plan; patient education and counseling on contraception; and follow-up
 13 services related to the drugs, devices, products, and procedures covered
 14 under this clause, including, but not limited to, management of side
 15 effects, counseling for continued adherence, and device insertion and
 16 removal. Except as otherwise authorized under this clause, a contract
 17 shall not impose any restrictions or delays on the coverage required
 18 under this clause. However, where the FDA has approved one or more
 19 therapeutic and pharmaceutical equivalent, as defined by the FDA,
 20 versions of a contraceptive drug, device, or product, a contract is not
 21 required to include all such therapeutic and pharmaceutical equivalent
 22 versions in its formulary, so long as at least one is included and
 23 covered without cost-sharing and in accordance with this clause. If the
 24 covered therapeutic and pharmaceutical equivalent versions of a drug,

 EXPLANATION--Matter in italics (underscored) is new; matter in brackets
 [ ] is old law to be omitted.
 LBD01380-01-5

 A. 3645 2

 1 device, or product are not available or are deemed medically inadvisable
 2 a contract shall provide coverage for an alternate therapeutic and phar-
 3 maceutical equivalent version of the contraceptive drug, device, or
 4 product without cost-sharing. (a) This coverage shall include emergency
 5 contraception without cost sharing when provided pursuant to a
 6 prescription, or order under section sixty-eight hundred thirty-one of
 7 the education law or when lawfully provided over-the-counter. (b) If the
 8 attending health care provider, in [his or her] their reasonable profes-
 9 sional judgment, determines that the use of a non-covered therapeutic or
 10 pharmaceutical equivalent of a drug, device, or product is warranted,
 11 the health care provider's determination shall be final. The superinten-
 12 dent shall promulgate regulations establishing a process, including
 13 timeframes, for an insured, an insured's designee or an insured's health
 14 care provider to request coverage of a non-covered contraceptive drug,
 15 device, or product. Such regulations shall include a requirement that
 16 insurers use an exception form that shall meet criteria established by
 17 the superintendent. (c) This coverage must allow